Student Recognition

 

2017 Graduate Symposium Research Day
 ORAL PRESENTATION


Second place (tie): Anthony Guastella

HONORABLE MENTION RECIPIENTS

James Block
Kayla Connor
Morenci Manning

 

 

Congratulations Ethan Brock, Anthony Guastella and Asra Shaik - F31 Fellowship Recipients

 

2017 - 2018  Komen GTDR Grant
Lucia Alfaro

Kayla Conner
Emily Girsch
Asra Shaik

 

2017 - 2018 CB T32 Training Grant 
Aamod Dekhne
Joshua Heyza
Laura Hurley
Brooke McKnight
Allison Mitchell
Donovan Watza

2017 - 2018 DeRoy Testamentary Fellowships
Daniel Luedtke
Andrew Murray

2017 - 2018 Thomas C Rumble Fellowship
Daniel Feldmann

 

2017 Molecular Therapeutics Annual Research Retreat
June 21, 2017
Poster Award

1st Prize - Joshua Heyza
2nd Prize - Rayna Rosati
3rd Place - Ethan Brock

Congratulations Ethan Brock - Awarded a National Institute of Health F31 Fellowship

Congratulations Anthony Guastella - Awarded a National Institute of Health F31 Fellowship

Inaugural Leonard N. Simons Award for Exemplary Research and Scholarly Achievement

Congratulations - Jonathan Diedrich

 

Congratulations to the following Cancer Biology Graduate Program Students for their outstanding achievement during the 7thAnnual Cancer Biology Research

Symposium held on Friday, March 31, 2017

Oral Presentation Awards
1st Prize - Joshua Heyza
2nd Prize - Brooke McKnight

Poster Presentation Awards
1st Prize - Rayna Rosati
2nd Prize -  Thomas McFall
3rd Prize - Brittany Haynes & C James Block

Congratulations Jonathan Diedrich - Awarded a National Institute of Health F31 Fellowship


Recent Awards and Honors

Wayne State University
C.P. Lee Graduate Student Research Day 2016
October 7, 2016

2nd Place - Daniel Luedtke

6th International Symposium on Folate Receptors & Transporters
Breckenridge, CO. September 19-23, 2016
Travel Awards

Steven Jones
Adrianne Wallace-Povirk

 

Congratulations! Andreana Holowatyj for being selected as Michigan's only representative during the inaugural AACR Capitol Hill Day to advocate for cancer research funding.

2016 Translational Research Cancer Centers Consortium For Emerging Therapies
Steven Jones - First Place Oral Presentation

Congratulations, Laura Hurley Okayama University Fellowship Exchange Recipient

2016 First Place Oral Presentation at Translational Research Cancer Centers Consortium For Emerging Therapies
Steven Jones
Folate Receptor Taregeted Delivery of SIRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated  Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance

 

Ivory Dean - Congratulations for representing the School of Medicine, Cancer Biology Graduate Program as the Student Commencement Speaker for the December 2014 Commencement Ceremony, Saturday, December 6, 2014.

 

Recent Student Publications
Listed Alphabetically by Student

Richard Arkwright

Farshi P, Deshmukh RR, Nwankwo JO, Arkwright RT, Cvek B, Liu J, Dou QP. Deubiquitinases (DUBs) and DUB inhibitors: a patent review. Farshi P, Deshmukh RR, Nwankwo JO, Arkwright RT, Cvek B, Liu J, Dou QP. Expert Opin Ther Pat. 2015;25:1191-208.

Arkwright RT, Deshmukh R, Adapa N, Stevens R, Zonder E, Zhang Z, Farshi P, Ahmed RS, El-Banna HA, Chan TH, Dou QP. Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics. Anticancer Agents Med Chem. 2015;15:657-71.

Ethan Brock

Brock EJ, Ji K, Reiners JJ Jr, Mattingly RR. How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization. Mini-Reviews in Medicinal Chemistry. 2015; Epub ahead of print.

Daniel Feldmann

Herroon MK, Rajagurubandara E, Hardaway AL, Powell K, Turchick A, Feldmann D, Podgorski I. Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms.Oncotarget. 2013;4:2108-23.

Anthony Guastella

Targeting the Broadly Pathogenic Kynurenine Pathway Guastella AR, Michelhaugh SK, Mittal S. 2015th ed. Mittal S, editor. New York: Springer; 2015. Chapter 25, Experimental models to study the kynurenine pathway. 480p.

Targeting the Broadly Pathogenic Kynurenine Pathway Michelhaugh SK, Guastella AR, Mittal S. 2015th ed. Mittal S, editor. New York: Springer; 2015. Chapter 1, Overview of the kynurenine pathway. 480p.

Targeting the Broadly Pathogenic Kynurenine Pathway Michelhaugh SK, Varadarajan K, Guastella AR, Mittal S. 2015th ed. Mittal S, editor. New York: Springer; 2015. Chapter 23, Role of kynurenine pathway in neuro-oncology. 480p.

Bosnyak E, Kamson DO, Guastella AR, Varadarajan K, Robinette NL, Kupsky WJ, Muzik O, Michelhaugh SK, Mittal S, Juhasz C. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas. Neuro-oncology (Charlottesville, Va) 2015. PMID: 26092774

Michelhaugh SK, Guastella AR, Varadarajan K, Klinger NV, Parajuli P, Ahmad A, Sethi S, Aboukameel A, Kiousis S, Zitron IM, Ebrahim SA, Polin LA, Sarkar FH, Bollig-Fischer A, and Mittal S. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. J Transl Med 2015;13:227.

Brittany Haynes

Haynes B, Zhang Y, Liu F, Li J, Petit S, Kothayer H, Bao X, Westwell AD, Mao G, Shekhar MP. Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterization. Nanomedicine: Nanotechnology, Biology and Medicine. 2015 Nov 9. pii: S1549-9634(15)00200-2.

Haynes B, Saadat N, Myung B, Shekhar MP. Crosstalk between translesion synthesis, Fanconi anemia network, and homologous recombination repair pathways in interstrand DNA crosslink repair and development of chemoresistance. Mutat Res Rev. 2015;763:258-66.

Joshua Heyza

Arora, S., Heyza, J., Zhang, H., Kalman-Maltese, V., Tillison, K., Floyd, A., Chalfin, E., Bepler, G., & Patrick, S. (2016). Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells. Oncotarget, 5. 2016 Sep 16.

Andreana Holowatyj

Ye Q*, Holowatyj A*, Wu J, Liu H, Zhang L, Suzuki T, Yang ZQ. Genetic alterations of KDM4 subfamily and therapeutic effect of novel demethylase inhibitor in breast cancer. Am J Cancer Res. 2015;5:1519-30. *Contributed equally to this work.

Holowatyj A, Yang ZQ, Pile L. Histone lysine demethylases in Drosophila melanogaster. Fly. 2015; Epub ahead of print.

Liu H, Liu L, Holowatyj A, Jiang Y, Yang, ZQ. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer. Molecular Carcinogenesis. 2015; Epub ahead of print.

Liu L, Kimball S, Liu H, Holowatyj A, Yang ZQ. Genetic alterations of histone lysine methyltransferases and their significance in breast cancer. ONCOTARGET 2015;6:2466-83.

Steven Jones

Jones SK, Lizzio V, Merkel O. Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Co-polymer to Overcome TLR4 Driven Chemotherapy Resistance. Biomacromolecules. 2015 Dec 4. [Epub ahead of print]

Jones S, Merkel O. Indium-Labeling of siRNA for Small Animal SPECT Imaging. Methods Mol Biol. 2016;1372:79-88.

Thomas McFall

McFall T, Patki M, Rosati R, Ratnam M. Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges. Oncotarget 2015;6:33146-64.

McFall, T. B., Patki, M., Rosati, R., & Ratnam, M. Role of the short isoform of the progesterone receptor in hormone-regulated invasiveness of breast cancer cells at pre-and post-menopausal levels of estrogen and progesterone. Cancer Research, 2015;75:5038.

Andrew Murray

Type II transmembrane serine proteases as potential targets for cancer therapy. Murray AS, Varela FA, List K. Biol Chem. 2016;397:815-26.

Zoratti GL, Tanabe LM, Varela FA, Murray AS, Bergum C, Colombo É, Lang JE, Molinolo AA, Leduc R, Marsault E, Boerner J, List K. Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling. Nat Commun. 2015;6:6776.

Rayna Rosati

McFall T, Patki M, Rosati R, Ratnam M. Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges. Oncotarget 2015;6:33146-64.